Projects funded by the NCN
Pharmacogenomics of SGLT2 inhibitors - investigating the role of empagliflozin in epigenetic modification of non-coding RNA - sirtuin - Sodium-glucose cotransporter-2 axis after myocardial infarction
2022/45/N/NZ7/02461
Keywords:
sirtuins non-coding RNAs myocardial infarction heart failure empagliflozin SGLT2 inhibitors
Descriptors:
- NZ7_12: Prevention of human diseases
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Warszawski Uniwersytet Medyczny
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 21 - announced on 2022-03-28
Amount awarded: 208 866 PLN
Project start date (Y-m-d): 2023-02-15
Project end date (Y-m-d): 2026-02-14
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.